Genetic analysis

Cardiomyopathies: genetic counseling and analysis

Genetic analysis: precisely identify the underlying disease of cardiomyopathy

About the history: the structure of DNA was discovered in 1953, thanks to the studies of Rosalind Franklin, who was the first to imagine its helical structure. The images obtained were then used by Watson and Crick to prove their theory (1958), for which they won the Nobel Prize in 1962.

What is DNA, i.e. the genetic code?  Every single cell of any living organism contains DNA, a very complex structure composed mainly of a double strand, coiled around itself to form a double helix. DNA contains the genetic code, formed by an alphabet of only 4 letters (ATGC), aligned in different sequences of 3 consecutive letters, i.e. triplets, called "codons", allow to produce 20 fundamental amino acids (e.g. Arginine, Lysine, Glycine, Alanine, etc). These amino acids, in turn, by binding together, produce all the proteins necessary for the functioning of our body.

A "gene” consists of a variable number of codons, which encode amino acids, which are used to produce different individual proteins such as, for example, "Myosin", "Troponin T. or I", "Myosin-binding protein C", essential proteins for contraction of heart cells, or "Desmoplakin" for cell-cell adhesion, or "Titin".

In XNUMX the genetic code of man was analyzed and over XNUMX genes have been identified.

Where is DNA?  DNA is delicate and its integrity must be preserved. It is enclosed within the cell nucleus, where it replicates at each cell division in order to possibly keep the genetic information of that organism or individual intact. Unable to leave the nucleus, DNA needs an intermediary, called RNA, which copies the information encoded in the genes and transports it to the area of ​​the cell around the nucleus called "cytoplasm”, where proteins are assembled and main activities of the cell itself take place.

Messenger RNA, a molecule similar to DNA, but with only one strand, copies the code from the corresponding DNA, and functions as a template for each specific codon. Each codon produces its own amino acid and the amino acid sequence forms a protein of precise length and spatial conformation to ensure the function it will have to perform.

What happens if the code is altered, or is incorrectly transcribed?

Various errors can occur, called "mutations" or "variants", which produce a protein, for example, missing some parts, such as a book that is missing a few pages. A malfunctioning protein can be responsible for diseases, and therefore also Cardiomyopathies, which can be recognized at birth, more often in adulthood. If the "mutations" are transmitted to children, these diseases are defined "hereditary”, as in most cases, for example, of Cardiomyopathies. However, mutations can also play a positive role. They contribute to the diversity of individuals, for example. in children or in a population, so as to ensure the variability of the species and the continuous adaptation to the changing environment.

Today we know thousands of "mutations" in numerous genes that cause cardiomyopathies, although several genes still remain to be identified.

The search for "mutations" in genes known so far is important to well evaluate the patient who has cardiomyopathy and his family members.

Genetic analysis (NGS - next generation sequencing)allows to identify one or more mutations(also called " variants") of the genetic code in one or more genes, responsible for the development of cardiomyopathy. For each type of cardiomyopathy, the most frequently encountered gene groups are analyzed.

For example, XNUMX genes are initially analyzed for patients with hypertrophic cardiomyopathy: MYBPCXNUMX, MYHXNUMX, TNNTXNUMX, TNNIXNUMX, TPMXNUMX, ACTCXNUMX, MYLXNUMX, MYLXNUMX, GLA, LAMP XNUMX, PRKAGXNUMX, TTR. If genetic mutations in these genes are not identified, a more in-depth analysis may be requested by the cardiologist with extension of the analysis to further gene groups.

In some laboratories, a greater number of genes are immediately analyzed (e.g. 45 or 174) and in some cases it is also possible to examine the whole set of genes (Exome).

Genetic analysis allows to :

  • precisely identify the type of disease underlying Cardiomyopathy
  • choose the most appropriate therapy
  • carry out a more accurate assessment of the risk of evolution and complications in subsequent years, obviously together with other clinical and instrumental elements (for example: ECG, Echocardiogram, cardiac magnetic resonance, cardiorespiratory test, dynamic ECG)
  • check if there is familial transmission of Cardiomyopathy, by looking for the mutation in family members as well

With current techniques the detection of a genetic variant is more frequent if one cardiomyopathy has already been diagnosed, through ECG and ECHO, also in other family members (the probability is about 60%, while it is lower if it has not been found in family members, about 30%).

Genetic testing must be preceded by a genetic consultation, made by the geneticist or an experienced cardiologist, as well as the interpretation of the written report..

THE FUTURE : One of the objectives of scientific research is the correction of genetic mutations, to be used in treatment of cancers and hereditary genetic diseases, including cardiomyopathies. However, genetic modification involves numerous ethical dilemmas and is still under study.

Main articles on genetics

1005, 2023
Genetic testing and counseling in hypertrophic cardiomyopathy

When should the test be performed, do patients ask themselves? The answer is: following a certain diagnosis or reasonable suspicion of the disease. The same rules apply to children, with the addition that the test can very rarely be performed even in the prenatal age.

3004, 2023
Pediatric cardiomyopathies: initial encouraging results in gene therapy studies

Pediatric cardiomyopathies: initial encouraging results in gene therapy studies. This was discussed in Florence on 13-14 April 2023 at the congress "Advances in pediatric heart failure: congenital heart disease and cardiomyopathies", organized by Prof. Olivotto, Dr. Favilli (Florence) and Prof Kaski (London), and supported by the Menarini Foundation.

2111, 2022
Rare diseases: precision medicine and different patient management

Scientific and medical knowledge on rare diseases is sometimes scarce and inadequate. For a long time they have been ignored by doctors, researchers and institutions and scientific and political activities aimed at research in the field of rare diseases did not exist until a few years ago.

1503, 2021
Genetic analysis in pediatric age: when to do it?

If a parent has cardiomyopathy, should the minor child be subjected to genetic testing? On this delicate and complex subject there are specific guidelines at American and European level. Francesca Girolami, geneticist, who works at the Meyer pediatric hospital in Florence, tells us about it, where there is a Cardiogenetics laboratory belonging to the Pediatric Cardiology facility consisting of a team of two geneticists and seven cardiologists.

1503, 2021
When cardiology met genetic diagnostics

The Careggi “Genetic Diagnostics” in Florence is today a center of excellence in Italy for hereditary heart disease, and is an integral part of the team that allows us to reconstruct the familiarity of hypertrophic cardiomyopathies and to act as a powerful prevention tool. Francesca Torricelli, who managed the structure until 2016, followed its developments and extraordinary evolution over almost forty years.

2904, 2020
Genetics -10 questions and answers

10 questions on the genetics of Cardiomyopathies and answers with the relative answers from the team of specialists who are dedicated to this pathology.

Subscribe to AICARM NEWS
the AICARM APS Newsletter

Read our information on data processing Privacy Policy

Back to the top